Open grant, contract, and cooperative agreement listings with closing dates and contacts
Application success rates, funding priorities, and trends
Tips for applicants; human subjects research information; grant review and management resources; and commonly used funding mechanisms, including diversity and small business programs
Research program and staff contacts for researchers seeking funding
Grant programs for students, postdocs, and faculty
Labs, faculty, and research opportunities located on NIDDK campuses in Maryland and Arizona
Protocols, repositories, mouse models, plasmids, and more
Material transfer agreements, technology licensing, and public/private collaborations
Past and upcoming scientific meetings sponsored or hosted by NIDDK
Information about diabetes, digestive and liver diseases, kidney diseases, weight control and nutrition, urological diseases, endocrine and metabolic diseases, and hematological diseases
Enlaces a nuestra información en español sobre la diabetes, enfermedades digestivas y hígado, enfermedades renales, control de peso y la nutrición, enfermedades urológicas, enfermedades endocrinas y metabólicas, y enfermedades hematológicas
Diabetes, digestive, kidney diseases, obesity, weight and more
Current research studies and how you can volunteer
Health tips from Dr. Griffin Rodgers, Director of the NIDDK
Patient and provider resources including select CEUs
General information about what NIDDK offers and other frequently asked questions
Director and deputy director biographies, Dr. Rodgers' vision statement, and the Director's Update newsletter
Organizational structure and descriptions of offices and divisions
Staff search and staff listed by offices and divisions
President's budget request, congressional testimony, and other legislative information
Strategic plans, research progress reports, and statistical reports
NIDDK Advisory Council, Board of Scientific Advisors, and committees that coordinate research activities
Overview of programs that create and disseminate health information
Overview of NIDDK activities in each major research area, including research advances, research coordination, and health information
How to find current openings and related resources
Frequently asked questions about the Institute
Locations in Bethesda, Maryland and Phoenix, Arizona
News releases, research updates, grantee news, and newsletters
Media contacts, statistics, multimedia gallery, and more resources
Upcoming and past meetings
Social media, RSS feeds, and more
Patents, materials, and other research resources appear below. Some resources may be available for use through Material Transfer Agreements (MTAs) or licensing agreements.
A guide to animal models which have been used to study molecular mechanisms of Mammary Gland Development, Physiology and Tumorigenesis.
Stat 5a Knockout: Stat5a deficiency results in the loss of prolactin-dependent mammary gland development and lactogenesis.
Prolactin induces mammary gland development and lactogenesis. Binding of Prolactin to its receptor leads to the phosphorylation…
Floxed Bcl-x: Conditional knockout of pro-survival Bcl-x in primordial germ cells was used to study the balance between pro-aptoptotic Bax during embryogenesis.
Bcl-x is a pro-survival protein that opposes the pro-apoptotic action of Bax which…
Conditional knockout of Stat5a and Stat5b: Combined deletion of conserved Stat5a and Stat5b in mammary epithelium at different times during pregnancy reveal multiple distinct functions.
The signal transducer and activator of transcription (STAT…
Cre-recombinase under the control of mouse mammary tumor virus long terminal repeat (MMTV) was expressed in the salivary gland and mammary epithelial cells of adult mice, and induced recombination in all tissues.
The Cre recombinase from bacteriophage…
Cre-recombinase under the control of the whey acidic acid protein was only detected in alveolar epithelial epithelial cells of mammary tissue during lactation, and transcription occurred at all stages of mammary development.
The Cre recombinase from…
Selective inactivation of Stat 1 in mammary cells indicates that its effect as a tumor suppressor in breast is direct.
STAT1 is considered a tumor suppressor, but it is not known if this effect occurs directly in mammary cells or secondarily by…
Open studies conducted by NIDDK Principal Investigators appear below that are currently recruiting, not yet recruiting, or available for expanded access.